Ikarian Capital »

Dbv Technologies Sa shares owned by Ikarian Capital

Quarter-by-quarter ownership of Dbv Technologies Sa (DBVT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Dbv Technologies Sa

Tip: Access up to 7 years of quarterly data

All positions including Dbv Technologies Sa held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Dbv Technologies Sa by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $2.1M 525k 3.97

More positions owned by Ikarian Capital

Cidara Therapeutics Com New (CDTX)
Spdr Series Trust State Street Spd Put Option (XBI)
Amgen (AMGN)
Terns Pharmaceuticals (TERN)
Abivax Sa Sponsored Ads (ABVX)
Harrow Health (HROW)
Rapt Therapeutics Com New (RAPT)
Cytokinetics Com New (CYTK)
Jazz Pharmaceuticals Call Call Option
Soleno Therapeutics (SLNO)
Jazz Pharmaceuticals Shs Usd (JAZZ)
Maze Therapeatics (MAZE)
Omeros Corporation Call Option (OMER)
Praxis Precision Medicines I Com New (PRAX)
Olema Pharmaceuticals (OLMA)

View all positions for Ikarian Capital

Top funds holding Dbv Technologies Sa

Artisan Partners Limited Partnership
Vivo Capital
Baker Bros. Advisors
Octagon Capital Advisors
MPM Oncology Impact Management
Yiheng Capital
Ikarian Capital
Schonfeld Strategic Advisors
Adage Capital Partners GP
Millennium Management
UBS Group
New York State Common Retirement Fund
Atika Capital Management
Boothbay Fund Management
Sei Investments

View all funds holding Dbv Technologies Sa